Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
Clinical trial NCT04265872 · RECRUITING
Trial details
- NCT number
- NCT04265872
- Sponsor
- Baylor Research Institute
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2026-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.